Marwan Abboud

ElectroPhysiology Frontiers S.p.A. (EPF) Appoints Marwan Abboud as CTO

This new addition further strengthens the executive leadership team of EPF as the organization continues to grow.

ElectroPhysiology Frontiers S.p.A. (EPF) is excited to announce that Marwan Abboud has joined the executive leadership team as Chief Technology Officer. Marwan brings deep technical expertise and decades of experience in the development, manufacturing, validation, and approval of medical devices and catheter ablation systems. 

Prior to joining EPF, Marwan provided executive consulting services to technology transfer offices, inventors, and numerous startup companies involved in the development of novel and impactful medical technologies. Marwan has served as Chief Product Development Officer for Soundbite Medical, Inc an endovascular technology company, as Vice President, Advanced Research and Intellectual Property for Medtronic AF solutions and as Vice President, Research and Development for CryoCath Technologies Inc, acquired by Medtronic and now the gold standard ‘single-shot’ cryoablation system. 

Marwan is an active Member of the Professional Corporation of Engineers of Quebec (OIQ), a Senior Member of the Institute of Electrical and Electronic Engineers (IEEE) as well as a prolific inventor with over 100 worldwide patents and patent applications. In addition to his numerous engineering degrees, Marwan successfully completed the Executive Management and Advanced Leadership Program at McGill University. 

 

EPF
EPF

ElectroPhysiology Frontiers is a MedTech company that has developed an innovative, easy to use “single-shot” catheter ablation system to provide durable ablations and reduce the rate of recurrence of Atrial Fibrillation (AFib) after pulmonary vein isolation (PVI).

Location & Contact

Follow Our Progress

Image
Image